Detection of Transient Increase of Cerebral Blood Flow and Reversible Neuronal Dysfunction by Iodine-123-Iomazenil Single Photon Emission Computed Tomography After Cerebral Hyperperfusion Syndrome After Revascularization Surgery for Moyamoya Disease

2020 ◽  
Vol 141 ◽  
pp. 335-338
Author(s):  
Mami Yamasaki ◽  
Hideyuki Yoshioka ◽  
Kazuya Kanemaru ◽  
Takashi Yagi ◽  
Koji Hashimoto ◽  
...  
Keyword(s):  
Single Photon ◽  
Photon Emission ◽  
Emission Computed Tomography ◽  
Single Photon Emission ◽  
Cerebral Hyperperfusion Syndrome ◽  
Cerebral Hyperperfusion ◽  
Iodine 123 ◽  
Single Photon Emission Computed ◽  
Revascularization Surgery ◽  
Photon Emission Computed Tomography

Imaging with iodine-123-labelled radiopharmaceuticals

2011 ◽  
Author(s):  
Nikant Sabharwal ◽  
Chee Yee Loong ◽  
Andrew Kelion
Keyword(s):  
Single Photon ◽  
Photon Emission ◽  
Emission Tomography ◽  
Emission Computed Tomography ◽  
Single Photon Emission ◽  
Positron Emission ◽  
Iodine 123 ◽  
Single Photon Emission Computed ◽  
Meta Iodo Benzyl Guanidine ◽  
Photon Emission Computed Tomography

123I-labelled radiopharmaceuticals 206123I-meta-iodo-benzyl-guanidine (123I-MIBG) 208β‎-methyl-p-[123I]iodo-phenyl-pentadecanoic acid (123I-BMIPP) 210Nuclear cardiology techniques offer the potential to image aspects of myocardial physiology and metabolism which are not accessible to other imaging modalities. Positron emission tomography (PET) has been extensively used in this area, but for single photon emission computed tomography (SPECT) imaging the range of radiopharmaceuticals available is limited. Two radiopharmaceuticals labelled with iodine-123 (...

Sign in / Sign up

Export Citation Format

Share Document